VTAK (Catheter Precision, Inc.) Stock Analysis - SEC Filings

Catheter Precision, Inc. (VTAK) is a publicly traded Healthcare sector company. As of May 21, 2026, VTAK trades at $0.80 with a market cap of $2.23M and a P/E ratio of -0.05. VTAK moved -3.83% today. Year to date, VTAK is -61.62%; over the trailing twelve months it is -85.28%. Its 52-week range spans $0.75 to $33.06. Rallies surfaces VTAK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find VTAK SEC filings?

Rallies organizes VTAK SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

VTAK Key Metrics

Key financial metrics for VTAK
MetricValue
Price$0.80
Market Cap$2.23M
P/E Ratio-0.05
EPS$-15.90
Dividend Yield0.00%
52-Week High$33.06
52-Week Low$0.75
Volume572
Avg Volume0
Revenue (TTM)$819.00K
Net Income$-17.70M
Gross Margin92.31%

Latest VTAK News

Recent VTAK Insider Trades

  • COLOMBATTO MARTIN J sold 3 (~$1.201) on Jan 29, 2025.
  • JENKINS DAVID A bought 9.53K (~$5.69K) on Jan 23, 2024.
  • JENKINS DAVID A bought 9.53K (~$4.09K) on Jan 22, 2024.

VTAK Analyst Consensus

VTAK analyst coverage data. Average price target: $0.00.

Common questions about VTAK

Where can I find VTAK SEC filings?
Rallies organizes VTAK SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show VTAK 10-K and 10-Q filings?
Rallies organizes VTAK SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is VTAK research on Rallies investment advice?
No. Rallies provides research, data, and educational context for VTAK. It does not provide personalized investment advice.
VTAK

VTAK